Consumer Tooth Whiteners Belong In Homes; FDA Denies ADA Petition For Drug Status
This article was originally published in The Tan Sheet
Executive Summary
The American Dental Association’s 2009 petition does not support a drug designation for peroxide-containing tooth-whitening products, FDA responds. Further information is needed on formulations, mechanisms of action and safety profiles for FDA to determine whether the products meet the definition of a drug.
You may also be interested in...
FTC Review Of Colgate Optic White Claims Delays Class Action Complaint
A Colgate Optic White whitening claims class action complaint is stayed pending an FTC decision on the claims, a federal judge rules. The judge denied the Colgate's motion to dismiss on the grounds the state suit is pre-empted by FDA regulations.
FTC Review Of Colgate Optic White Claims Delays Class Action Complaint
A Colgate Optic White whitening claims class action complaint is stayed pending an FTC decision on the claims, a federal judge rules. The judge denied the Colgate's motion to dismiss on the grounds the state suit is pre-empted by FDA regulations.
P&G Defends Tooth Whitening Cosmetic Classification In FDA Letter
Procter & Gamble urges FDA to deny a citizen petition by the American Dental Association to reclassify commercially available tooth-whiteners as drugs, saying ADA members' financial interests motivated the petition